Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IgA nephropathy
IgA nephropathy
Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts
Motley Fool
Mon, 12/18/23 - 11:35 am
Vera Therapeutics
IgA nephropathy
As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease
Fierce Pharma
Fri, 11/3/23 - 10:53 am
Travere Therapeutics
Filspari
IgA nephropathy
kidney disease
FDA
Atrasentan data backs up Novartis’ $3.5bn Chinook deal
Pharmaphorum
Mon, 10/30/23 - 10:21 am
Novartis
IgA nephropathy
atrasentan
Chinook Therapeutics
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Clinical Trials Arena
Mon, 10/2/23 - 10:14 am
Novartis
clinical trials
iptacopan
IgA nephropathy
kidney disease
Travere’s Filspari reduces urine protein levels in adults with IgAN
Clinical Trials Arena
Mon, 04/3/23 - 09:50 am
Travere Therapeutics
Filspari
IgA nephropathy
clinical trials
Calliditas is Getting to the Heart of Berger’s Disease
BioSpace
Thu, 06/3/21 - 12:05 am
Calliditas
IgA nephropathy
Berger's disease
With industry's growing kidney moment, Everest begins building kidney portfolio
BioCentury
Mon, 06/10/19 - 09:29 am
Everest Medicines
Calliditas
Nefecon
clinical trials
IgA nephropathy
kidney disease